Closely monitor vital signs, including heart rate, blood pressure, and rhythm, continuously during Cardizem infusion. Target a heart rate between 60-80 bpm, adjusting the drip rate accordingly.
- Continuous ECG monitoring: This is critical for detecting any adverse effects like bradycardia or hypotension. Blood pressure monitoring: Check blood pressure every 5-15 minutes initially, then less frequently as the patient stabilizes, but always maintain close observation. Heart rate monitoring: Continuously monitor the heart rate and rhythm. Document any changes immediately.
Observe the patient for signs of hypotension: dizziness, lightheadedness, syncope. Report any significant changes promptly to the physician.
Assess for adverse effects: These include nausea, vomiting, headache, and flushing. Administer appropriate antiemetics if necessary. Monitor for AV block: Carefully observe for signs of worsening AV block, requiring potential intervention or medication adjustment. Fluid status: Monitor intake and output to prevent fluid overload or dehydration.
Maintain accurate documentation of all findings, including infusion rates, vital signs, medication adjustments, and any observed adverse events. This ensures clear communication between healthcare providers.
- Lab work: Consider periodic electrolyte monitoring, particularly potassium levels, which can be influenced by Cardizem. Physician communication: Report any concerning changes immediately to the attending physician.
Remember, diligent monitoring is paramount to safe and effective management of Afib using a Cardizem drip.
